Outlook for orphan PRMA environment in the US, EU4, and UK.
Jack Mycka
Advertisement
Vice president, pricing, reimbursement, and market access (PRMA), and emerging biotech commercialization, MME, an Indegene PRMA business
Articles by Jack Mycka
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
